Related Experiment Video
Updated: Mar 9, 2026
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Young microglia restore amyloid plaque clearance of aged microglia
Anna Daria1, Alessio Colombo2, Gemma Llovera3
1Biomedical Center (BMC), Ludwig-Maximilians Universität München, Munich, Germany.
Abstract:
Alzheimer's disease (AD) is characterized by deposition of amyloid plaques, neurofibrillary tangles, and neuroinflammation. In order to study microglial contribution to amyloid plaque phagocytosis, we developed a novel ex vivo model by co-culturing organotypic brain slices from up to 20-month-old, amyloid-bearing AD mouse model (APPPS1) and young, neonatal wild-type (WT) mice. Surprisingly, co-culturing resulted in proliferation, recruitment, and clustering of old microglial cells around amyloid plaques and clearance of the plaque halo. Depletion of either old or young microglial cells prevented amyloid plaque clearance, indicating a synergistic effect of both populations. Exposing old microglial cells to conditioned media of young microglia or addition of granulocyte-macrophage colony-stimulating factor (GM-CSF) was sufficient to induce microglial proliferation and reduce amyloid plaque size. Our data suggest that microglial dysfunction in AD may be reversible and their phagocytic ability can be modulated to limit amyloid accumulation. This novel ex vivo model provides a valuable system for identification, screening, and testing of compounds aimed to therapeutically reinforce microglial phagocytosis.
Insights
Researchers developed a novel ex vivo model to study Alzheimer's disease (AD) and found that combining old and young microglia clears amyloid plaques. This suggests microglial dysfunction in AD may be reversible.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) is marked by amyloid plaques, neurofibrillary tangles, and neuroinflammation.
- Microglia play a crucial role in brain immune responses and are implicated in AD pathogenesis.
Purpose of the Study:
- To investigate microglial contribution to amyloid plaque phagocytosis in Alzheimer's disease.
- To develop and validate a novel ex vivo model for studying microglial function in AD.
Main Methods:
- Co-culturing organotypic brain slices from aged amyloid-bearing AD mouse models (APPPS1) and young wild-type (WT) mice.
- Utilizing an ex vivo system to observe microglial behavior and amyloid plaque clearance.
Main Results:
- Co-culturing induced proliferation, recruitment, and clustering of aged microglia around amyloid plaques, leading to plaque halo clearance.
- Depletion of either aged or young microglia impaired amyloid plaque clearance, highlighting a synergistic effect.
- Exposure to young microglia conditioned media or GM-CSF stimulated aged microglia proliferation and reduced plaque size.
Conclusions:
- Microglial dysfunction in Alzheimer's disease may be reversible.
- Microglial phagocytic activity can be modulated to reduce amyloid accumulation.
- The developed ex vivo model is valuable for identifying and testing therapeutic compounds targeting microglial phagocytosis.
